Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

The Differential Anti-HIV Effect of a New Humic Substance-Derived Preparation in Diverse Cells of the Immune System.

Kornilaeva GV, Siniavin AE, Schultz A, Germann A, Moog C, von Briesen H, Turgiev AS, Karamov EV.

Acta Naturae. 2019 Apr-Jun;11(2):68-76. doi: 10.32607/20758251-2019-11-2-68-76.

2.

Multi-endpoint toxicological assessment of polystyrene nano- and microparticles in different biological models in vitro.

Hesler M, Aengenheister L, Ellinger B, Drexel R, Straskraba S, Jost C, Wagner S, Meier F, von Briesen H, Büchel C, Wick P, Buerki-Thurnherr T, Kohl Y.

Toxicol In Vitro. 2019 Jul 27;61:104610. doi: 10.1016/j.tiv.2019.104610. [Epub ahead of print]

3.

Age-Related Loss of Human Vitreal Viscoelasticity.

Schulz A, Wahl S, Rickmann A, Ludwig J, Stanzel BV, von Briesen H, Szurman P.

Transl Vis Sci Technol. 2019 Jun 28;8(3):56. doi: 10.1167/tvst.8.3.56. eCollection 2019 May.

4.

Trends in characteristics of 24-h urine samples and their relevance for human biomonitoring studies - 20 years of experience in the German Environmental Specimen Bank.

Lermen D, Bartel-Steinbach M, Gwinner F, Conrad A, Weber T, von Briesen H, Kolossa-Gehring M.

Int J Hyg Environ Health. 2019 Jun;222(5):831-839. doi: 10.1016/j.ijheh.2019.04.009. Epub 2019 Apr 26.

5.

Peptide Assembly on the Membrane Determines the HIV-1 Inhibitory Activity of Dual-Targeting Fusion Inhibitor Peptides.

Gomara MJ, Perez Y, Martinez JP, Barnadas-Rodriguez R, Schultz A, von Briesen H, Peralvarez-Marin A, Meyerhans A, Haro I.

Sci Rep. 2019 Mar 1;9(1):3257. doi: 10.1038/s41598-019-40125-4.

6.

Tyramine-conjugated alginate hydrogels as a platform for bioactive scaffolds.

Schulz A, Gepp MM, Stracke F, von Briesen H, Neubauer JC, Zimmermann H.

J Biomed Mater Res A. 2019 Jan;107(1):114-121. doi: 10.1002/jbm.a.36538. Epub 2018 Sep 26.

7.

Poly(amidoamine)-alginate hydrogels: directing the behavior of mesenchymal stem cells with charged hydrogel surfaces.

Schulz A, Katsen-Globa A, Huber EJ, Mueller SC, Kreiner A, Pütz N, Gepp MM, Fischer B, Stracke F, von Briesen H, Neubauer JC, Zimmermann H.

J Mater Sci Mater Med. 2018 Jun 30;29(7):105. doi: 10.1007/s10856-018-6113-x.

8.

Towards a Full Automation of the ELISpot Assay for Safe and Parallelized Immunomonitoring.

Neubauer JC, Sébastien I, Germann A, von Briesen H, Zimmermann H.

Methods Mol Biol. 2018;1808:237-247. doi: 10.1007/978-1-4939-8567-8_20.

PMID:
29956188
9.

Validation of an automated system for aliquoting of HIV-1 Env-pseudotyped virus stocks.

Schultz A, Germann A, Fuss M, Sarzotti-Kelsoe M, Ozaki DA, Montefiori DC, Zimmermann H, von Briesen H.

PLoS One. 2018 Jan 4;13(1):e0190669. doi: 10.1371/journal.pone.0190669. eCollection 2018.

10.

Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers.

Koch K, Kalusche S, Torres JL, Stanfield RL, Danquah W, Khazanehdari K, von Briesen H, Geertsma ER, Wilson IA, Wernery U, Koch-Nolte F, Ward AB, Dietrich U.

Sci Rep. 2017 Aug 21;7(1):8390. doi: 10.1038/s41598-017-08273-7.

11.

Towards standardized automated immunomonitoring: an automated ELISpot assay for safe and parallelized functionality analysis of immune cells.

Neubauer JC, Sébastien I, Germann A, Müller SC, Meyerhans A, von Briesen H, Zimmermann H.

Cytotechnology. 2017 Feb;69(1):57-73. doi: 10.1007/s10616-016-0037-4. Epub 2016 Nov 28.

12.

Toward Optimal Cryopreservation and Storage for Achievement of High Cell Recovery and Maintenance of Cell Viability and T Cell Functionality.

Angel S, von Briesen H, Oh YJ, Baller MK, Zimmermann H, Germann A.

Biopreserv Biobank. 2016 Dec;14(6):539-547. Epub 2016 Oct 28.

13.

Quantitative bioimaging of platinum group elements in tumor spheroids.

Niehoff AC, Grünebaum J, Moosmann A, Mulac D, Söbbing J, Niehaus R, Buchholz R, Kröger S, Wiehe A, Wagner S, Sperling M, von Briesen H, Langer K, Karst U.

Anal Chim Acta. 2016 Sep 28;938:106-13. doi: 10.1016/j.aca.2016.07.021. Epub 2016 Jul 25.

PMID:
27619092
14.

Cryopreservation of Human Mucosal Leukocytes.

Hughes SM, Shu Z, Levy CN, Ferre AL, Hartig H, Fang C, Lentz G, Fialkow M, Kirby AC, Adams Waldorf KM, Veazey RS, Germann A, von Briesen H, McElrath MJ, Dezzutti CS, Sinclair E, Baker CA, Shacklett BL, Gao D, Hladik F.

PLoS One. 2016 May 27;11(5):e0156293. doi: 10.1371/journal.pone.0156293. eCollection 2016.

15.

Ligand-Modified Human Serum Albumin Nanoparticles for Enhanced Gene Delivery.

Look J, Wilhelm N, von Briesen H, Noske N, Günther C, Langer K, Gorjup E.

Mol Pharm. 2015 Sep 8;12(9):3202-13. doi: 10.1021/acs.molpharmaceut.5b00153. Epub 2015 Aug 14.

PMID:
26218774
16.

A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis.

Latorre I, Leidinger P, Backes C, Domínguez J, de Souza-Galvão ML, Maldonado J, Prat C, Ruiz-Manzano J, Sánchez F, Casas I, Keller A, von Briesen H, Knobel H, Meese E, Meyerhans A.

Eur Respir J. 2015 Apr;45(4):1173-6. doi: 10.1183/09031936.00221514. Epub 2015 Feb 5. No abstract available.

17.

A new approach to standardize multicenter studies: mobile lab technology for the German Environmental Specimen Bank.

Lermen D, Schmitt D, Bartel-Steinbach M, Schröter-Kermani C, Kolossa-Gehring M, von Briesen H, Zimmermann H.

PLoS One. 2014 Aug 20;9(8):e105401. doi: 10.1371/journal.pone.0105401. eCollection 2014.

18.

Freeze-drying of HI-6-loaded recombinant human serum albumin nanoparticles for improved storage stability.

Dadparvar M, Wagner S, Wien S, Worek F, von Briesen H, Kreuter J.

Eur J Pharm Biopharm. 2014 Oct;88(2):510-7. doi: 10.1016/j.ejpb.2014.06.008. Epub 2014 Jul 1.

PMID:
24995841
19.

Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody.

Trott M, Weiβ S, Antoni S, Koch J, von Briesen H, Hust M, Dietrich U.

PLoS One. 2014 May 14;9(5):e97478. doi: 10.1371/journal.pone.0097478. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e107089.

20.

Tracking of magnetite labeled nanoparticles in the rat brain using MRI.

Martínez Vera NP, Schmidt R, Langer K, Zlatev I, Wronski R, Auer E, Havas D, Windisch M, von Briesen H, Wagner S, Stab J, Deutsch M, Pietrzik C, Fazekas F, Ropele S.

PLoS One. 2014 Mar 14;9(3):e92068. doi: 10.1371/journal.pone.0092068. eCollection 2014.

21.

A palladium label to monitor nanoparticle-assisted drug delivery of a photosensitizer into tumor spheroids by elemental bioimaging.

Niehoff AC, Moosmann A, Söbbing J, Wiehe A, Mulac D, Wehe CA, Reifschneider O, Blaske F, Wagner S, Sperling M, von Briesen H, Langer K, Karst U.

Metallomics. 2014 Jan;6(1):77-81. doi: 10.1039/c3mt00223c.

PMID:
24311052
22.

Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood-brain barrier model.

Meister S, Zlatev I, Stab J, Docter D, Baches S, Stauber RH, Deutsch M, Schmidt R, Ropele S, Windisch M, Langer K, Wagner S, von Briesen H, Weggen S, Pietrzik CU.

Alzheimers Res Ther. 2013 Nov 27;5(6):51. doi: 10.1186/alzrt225. eCollection 2013.

23.

Temperature fluctuations during deep temperature cryopreservation reduce PBMC recovery, viability and T-cell function.

Germann A, Oh YJ, Schmidt T, Schön U, Zimmermann H, von Briesen H.

Cryobiology. 2013 Oct;67(2):193-200. doi: 10.1016/j.cryobiol.2013.06.012. Epub 2013 Jul 9.

24.

An automated HIV-1 Env-pseudotyped virus production for global HIV vaccine trials.

Schultz A, Koch S, Fuss M, Mazzotta AS, Sarzotti-Kelsoe M, Ozaki DA, Montefiori DC, von Briesen H, Zimmermann H, Meyerhans A.

PLoS One. 2012;7(12):e51715. doi: 10.1371/journal.pone.0051715. Epub 2012 Dec 27.

25.

Staphylococcal disease in Africa: another neglected 'tropical' disease.

Herrmann M, Abdullah S, Alabi A, Alonso P, Friedrich AW, Fuhr G, Germann A, Kern WV, Kremsner PG, Mandomando I, Mellmann AC, Pluschke G, Rieg S, Ruffing U, Schaumburg F, Tanner M, Peters G, von Briesen H, von Eiff C, von Müller L, Grobusch MP.

Future Microbiol. 2013 Jan;8(1):17-26. doi: 10.2217/fmb.12.126. Review.

PMID:
23252490
26.

Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library.

Zhou M, Meyer T, Koch S, Koch J, von Briesen H, Benito JM, Soriano V, Haberl A, Bickel M, Dübel S, Hust M, Dietrich U.

Eur J Immunol. 2013 Feb;43(2):499-509. doi: 10.1002/eji.201242974. Epub 2012 Dec 27.

27.

Towards a xeno-free and fully chemically defined cryopreservation medium for maintaining viability, recovery, and antigen-specific functionality of PBMC during long-term storage.

Schulz JC, Germann A, Kemp-Kamke B, Mazzotta A, von Briesen H, Zimmermann H.

J Immunol Methods. 2012 Aug 31;382(1-2):24-31. doi: 10.1016/j.jim.2012.05.001. Epub 2012 May 8.

28.

Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model.

Wagner S, Zensi A, Wien SL, Tschickardt SE, Maier W, Vogel T, Worek F, Pietrzik CU, Kreuter J, von Briesen H.

PLoS One. 2012;7(3):e32568. doi: 10.1371/journal.pone.0032568. Epub 2012 Mar 1.

29.
30.

Biocompatible micro-sized cell culture chamber for the detection of nanoparticle-induced IL8 promoter activity on a small cell population.

Kohl Y, Oostingh GJ, Sossalla A, Duschl A, von Briesen H, Thielecke H.

Nanoscale Res Lett. 2011 Aug 23;6:505. doi: 10.1186/1556-276X-6-505.

31.

HI 6 human serum albumin nanoparticles--development and transport over an in vitro blood-brain barrier model.

Dadparvar M, Wagner S, Wien S, Kufleitner J, Worek F, von Briesen H, Kreuter J.

Toxicol Lett. 2011 Sep 25;206(1):60-6. doi: 10.1016/j.toxlet.2011.06.027. Epub 2011 Jun 24.

PMID:
21726608
32.

Cytotoxicity of Triptolide and Triptolide loaded polymeric micelles in vitro.

Zheng S, Löw K, Wagner S, Yang X, von Briesen H, Zou S.

Toxicol In Vitro. 2011 Dec;25(8):1557-67. doi: 10.1016/j.tiv.2011.05.020. Epub 2011 May 27.

PMID:
21640813
33.

Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells.

Löw K, Knobloch T, Wagner S, Wiehe A, Engel A, Langer K, von Briesen H.

Nanotechnology. 2011 Jun 17;22(24):245102. doi: 10.1088/0957-4484/22/24/245102. Epub 2011 Apr 20.

PMID:
21508461
34.

Targeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cells.

Löw K, Wacker M, Wagner S, Langer K, von Briesen H.

Nanomedicine. 2011 Aug;7(4):454-63. doi: 10.1016/j.nano.2010.12.003. Epub 2011 Jan 5.

PMID:
21215330
35.

Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.

Wagner S, Kufleitner J, Zensi A, Dadparvar M, Wien S, Bungert J, Vogel T, Worek F, Kreuter J, von Briesen H.

PLoS One. 2010 Dec 3;5(12):e14213. doi: 10.1371/journal.pone.0014213.

36.

Regulation of HIV-1 infection in cells derived from purified CD34+ cells through manipulation of APOBEC3G expression.

Heinzelmann A, Stein S, Köhl U, Dietrich U, von Briesen H.

Curr HIV Res. 2010 Oct;8(7):554-63.

PMID:
20642434
37.

Adsorption of obidoxime onto human serum albumin nanoparticles: drug loading, particle size and drug release.

Kufleitner J, Wagner S, Worek F, von Briesen H, Kreuter J.

J Microencapsul. 2010;27(6):506-13. doi: 10.3109/02652041003681406.

PMID:
20214419
38.

Neuro-muscular differentiation of adult porcine skin derived stem cell-like cells.

Lermen D, Gorjup E, Dyce PW, von Briesen H, Müller P.

PLoS One. 2010 Jan 29;5(1):e8968. doi: 10.1371/journal.pone.0008968.

39.

Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles.

Wagner S, Rothweiler F, Anhorn MG, Sauer D, Riemann I, Weiss EC, Katsen-Globa A, Michaelis M, Cinatl J Jr, Schwartz D, Kreuter J, von Briesen H, Langer K.

Biomaterials. 2010 Mar;31(8):2388-98. doi: 10.1016/j.biomaterials.2009.11.093. Epub 2009 Dec 23.

PMID:
20031203
40.

Glandular tissue from human pancreas and salivary gland yields similar stem cell populations.

Gorjup E, Danner S, Rotter N, Habermann J, Brassat U, Brummendorf TH, Wien S, Meyerhans A, Wollenberg B, Kruse C, von Briesen H.

Eur J Cell Biol. 2009 Jul;88(7):409-21. doi: 10.1016/j.ejcb.2009.02.187. Epub 2009 May 2. Erratum in: Eur J Cell Biol. 2010 Apr;89(4):349.

PMID:
19410331
41.

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Wagner S, Büchel C, von Briesen H, Kreuter J.

J Control Release. 2009 Jul 1;137(1):78-86. doi: 10.1016/j.jconrel.2009.03.002. Epub 2009 Mar 11.

PMID:
19285109
42.

Directed differentiation of pancreatic stem cells by soluble and immobilised signalling factors.

Brose C, Schmitt D, von Briesen H, Reimann M.

Ann Anat. 2009 Jan;191(1):83-93. doi: 10.1016/j.aanat.2008.09.004. Epub 2008 Nov 1.

PMID:
19081233
43.

Stirred bioreactors for the expansion of adult pancreatic stem cells.

Serra M, Brito C, Leite SB, Gorjup E, von Briesen H, Carrondo MJ, Alves PM.

Ann Anat. 2009 Jan;191(1):104-15. doi: 10.1016/j.aanat.2008.09.005. Epub 2008 Nov 1.

PMID:
19054658
44.

Automated microscopic quantification of adipogenic differentiation of human gland stem cells.

Gorjup E, Peter L, Wien S, von Briesen H, Schmitt D.

Ann Anat. 2009 Jan;191(1):13-22. doi: 10.1016/j.aanat.2008.09.003. Epub 2008 Oct 22.

PMID:
19046627
45.

Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles.

Anhorn MG, Wagner S, Kreuter J, Langer K, von Briesen H.

Bioconjug Chem. 2008 Dec;19(12):2321-31. doi: 10.1021/bc8002452.

PMID:
18937508
46.

Immobilized cytokines as biomaterials for manufacturing immune cell based vaccines.

Leclerc C, Brose C, Nouzé C, Leonard F, Majlessi L, Becker S, von Briesen H, Lo-Man R.

J Biomed Mater Res A. 2008 Sep 15;86(4):1033-40.

PMID:
18067172
47.

Skin-derived human adult stem cells surprisingly share many features with human pancreatic stem cells.

Kajahn J, Gorjup E, Tiede S, von Briesen H, Paus R, Kruse C, Danner S.

Eur J Cell Biol. 2008 Jan;87(1):39-46. Epub 2007 Sep 19.

PMID:
17881083
48.

Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays.

De Juan BS, Von Briesen H, Gelperina SE, Kreuter J.

J Drug Target. 2006 Nov;14(9):614-22.

PMID:
17090397
49.

Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages.

Bouazzaoui A, Kreutz M, Eisert V, Dinauer N, Heinzelmann A, Hallenberger S, Strayle J, Walker R, Rübsamen-Waigmann H, Andreesen R, von Briesen H.

Virology. 2006 Dec 5-20;356(1-2):79-94. Epub 2006 Aug 22.

50.

Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?

Leroy V, Sakarovitch C, Cortina-Borja M, McIntyre J, Coovadia H, Dabis F, Newell ML, Saba J, Gray G, Ndugwa Ch, Kilewo Ch, Massawe A, Kituuka P, Okong P, Grulich A, von Briesen H, Goudsmit J, Biberfeld G, Haverkamp G, Weverling GJ, Lange JM; Ghent Group on HIV in Women and Children.

AIDS. 2005 Nov 4;19(16):1865-75.

PMID:
16227795

Supplemental Content

Loading ...
Support Center